Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The effect of tesofensine on appetite sensations.

Gilbert JA, Gasteyger C, Raben A, Meier DH, Astrup A, Sjödin A.

Obesity (Silver Spring). 2012 Mar;20(3):553-61. doi: 10.1038/oby.2011.197. Epub 2011 Jun 30.

2.

The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men.

Sjödin A, Gasteyger C, Nielsen AL, Raben A, Mikkelsen JD, Jensen JK, Meier D, Astrup A.

Int J Obes (Lond). 2010 Nov;34(11):1634-43. doi: 10.1038/ijo.2010.87. Epub 2010 May 18.

PMID:
20479765
3.

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.

Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM.

Lancet. 2008 Nov 29;372(9653):1906-13. doi: 10.1016/S0140-6736(08)61525-1. Epub 2008 Oct 22.

PMID:
18950853
4.

Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease.

Astrup A, Meier DH, Mikkelsen BO, Villumsen JS, Larsen TM.

Obesity (Silver Spring). 2008 Jun;16(6):1363-9. doi: 10.1038/oby.2008.56. Epub 2008 Mar 20.

5.

[The effect of tesofensine on body weight and body composition in obese subjects--secondary publication].

Nielsen AL, Larsen TM, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Astrup A.

Ugeskr Laeger. 2009 Oct 5;171(41):2974-7. Danish.

PMID:
19824222
6.

Tesofensine, a monoamine reuptake inhibitor for the treatment of obesity.

Bello NT, Zahner MR.

Curr Opin Investig Drugs. 2009 Oct;10(10):1105-16. Review.

PMID:
19777399
7.

Efficacy of Olibra: a 12-week randomized controlled trial and a review of earlier studies.

Rebello CJ, Martin CK, Johnson WD, O'Neil CE, Greenway FL.

J Diabetes Sci Technol. 2012 May 1;6(3):695-708. Review.

9.

Milk supplementation facilitates appetite control in obese women during weight loss: a randomised, single-blind, placebo-controlled trial.

Gilbert JA, Joanisse DR, Chaput JP, Miegueu P, Cianflone K, Alméras N, Tremblay A.

Br J Nutr. 2011 Jan;105(1):133-43. doi: 10.1017/S0007114510003119.

PMID:
21205360
10.

Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats.

Bentzen BH, Grunnet M, Hyveled-Nielsen L, Sundgreen C, Lassen JB, Hansen HH.

Obesity (Silver Spring). 2013 May;21(5):985-92. doi: 10.1002/oby.20122.

11.

The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant.

Hansen HH, Hansen G, Tang-Christensen M, Larsen PJ, Axel AM, Raben A, Mikkelsen JD.

Eur J Pharmacol. 2010 Jun 25;636(1-3):88-95. doi: 10.1016/j.ejphar.2010.03.026. Epub 2010 Apr 10.

PMID:
20385125
12.

Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat.

Hansen HH, Jensen MM, Overgaard A, Weikop P, Mikkelsen JD.

Pharmacol Biochem Behav. 2013 Sep;110:265-71. doi: 10.1016/j.pbb.2013.07.018. Epub 2013 Aug 7.

PMID:
23932919
13.

Serotonergic anti-obesity agents: past experience and future prospects.

Halford JC, Boyland EJ, Lawton CL, Blundell JE, Harrold JA.

Drugs. 2011 Dec 3;71(17):2247-55. doi: 10.2165/11596680-000000000-00000. Review.

PMID:
22085383
14.
15.

Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects.

Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS.

Eur J Clin Nutr. 2003 Oct;57(10):1268-74.

PMID:
14506488
16.

Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.

Ravussin E, Smith SR, Mitchell JA, Shringarpure R, Shan K, Maier H, Koda JE, Weyer C.

Obesity (Silver Spring). 2009 Sep;17(9):1736-43. doi: 10.1038/oby.2009.184. Epub 2009 Jun 11.

17.

The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.

Tremblay A, Chaput JP, Bérubé-Parent S, Prud'homme D, Leblanc C, Alméras N, Després JP.

Eur J Clin Pharmacol. 2007 Feb;63(2):123-34. Epub 2007 Jan 3.

PMID:
17200837
18.

Zonisamide for weight loss in obese adults: a randomized controlled trial.

Gadde KM, Franciscy DM, Wagner HR 2nd, Krishnan KR.

JAMA. 2003 Apr 9;289(14):1820-5.

PMID:
12684361
19.

Satiety and amino-acid profile in overweight women after a new treatment using a natural plant extract sublingual spray formulation.

Rondanelli M, Klersy C, Iadarola P, Monteferrario F, Opizzi A.

Int J Obes (Lond). 2009 Oct;33(10):1174-82. doi: 10.1038/ijo.2009.155. Epub 2009 Sep 15.

PMID:
19752879
20.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755

Supplemental Content

Support Center